OR5H6

Q-omics provides the consensus-scored OR5H6 profile across patient tissues and cancer cell-line models. OR5H6 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in SCLC. Additionally, OR5H6 mutation status shows 1,214 significant gene co-expression associations, with the highest sampling consensus in UCEC. Together, these results highlight SCLC, and UCEC as cancer lineages where OR5H6 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes OR5H6 survival associations across molecular data types. OR5H6 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

OR5H6 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	SCLC (9)	view →

This table ranks reproducible OR5H6 RNA expression–survival associations across cancer types. High OR5H6 expression shows unfavorable associations in SCLC. The SCLC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .042). Together, the overview and detailed table identify SCLC as the clearest survival context for OR5H6 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Tertile	All	0.214	0.582	.042	9	view →

Pink = unfavorable, green = favorable. all 1 lineages →

OR5H6-SCLC (OS)

Explore this curve interactively →